BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Bio NC

  Metabolon Raises Additional $15 Million In Funding From Essex Woodlands

  December 6, 2016

   · 

  3 min read
• Business

  Theresa LaVallee, Ph.D., Joins Celldex’ Senior Management Team

  December 6, 2016

   · 

  5 min read
• Teewinot Life Sciences’ Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures A New U.S. Patent Covering An Apparatus For Biosynthetic Production Of Authentic THCA, CBDA And CBCA Cannabinoids

  December 6, 2016

   · 

  2 min read
• Drug Development

  Resverlogix Announces Second Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study Of Apabetalone (RVX-208)

  December 6, 2016

   · 

  3 min read
• Business

  SoCal’s Inogen Taps a New CEO

  December 6, 2016

   · 

  12 min read
• Business

  Abyrx Announces Expansion Of Exclusive, Worldwide License Agreement With Bezwada Biomedical; Completes $10M Equity Financing.

  December 6, 2016

   · 

  3 min read
• Drug Development

  Senhwa Biosciences CX-4945 Phase I Clinical Trial Results Accepted For Presentation At The 2017 ASCO Gastrointestinal Cancers Symposium

  December 6, 2016

   · 

  2 min read
• Business

  BioQ Enters Into Strategic Partnership With Galen Limited To Commercialize Three Ready-To-Use Infusion Products In The United Kingdom And Ireland

  December 6, 2016

   · 

  1 min read
• Deals

  Reata Pharmaceuticals, Inc. Announces Filing Of Registration Statement For Proposed Public Offering

  December 6, 2016

   · 

  4 min read
• Drug Development

  Achillion Release: Data Presented At American Society of Hematology Meeting Demonstrate Potential Advantages Of Factor D Inhibition For The Treatment Of Complement Alternative Pathway-Mediated Diseases

  December 6, 2016

   · 

  6 min read